Atypical Antipsychotic
WHO आवश्यक दवा EML अनुभाग: Medicines used in psychotic disorders
यह केवल जानकारी है, प्रिस्क्रिप्शन नहीं। कोई भी दवा लेने से पहले डॉक्टर या फार्मासिस्ट से सलाह लें। ओवरडोज़/विषाक्तता पर 102 पर कॉल करें।
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Paliperidone extended-release tablets are not approved for the treatment of patients with dementia-related psychosis.
Nepal brand names not included: no licence-safe source.
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia Adults: Efficacy was established in three 6-week trials and one maintenance trial. Adolescents (ages 12 to 17): Efficacy was established in one 6-week trial. Treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants.
Paliperidone is the major active metabolite of risperidone. The mechanism of action of paliperidone in schizophrenia is unclear.
The following adverse reactions are discussed in more detail in other sections of the labeling: Increased mortality in elderly patients with dementia-related psychosis Cerebrovascular adverse reactions, including stroke, in elderly patients with dementia-related psychosis Neuroleptic malignant syndrome QT prolongation Tardive dyskinesia Metabolic...
Paliperidone extended-release tablets are contraindicated in patients with a known hypersensitivity to either paliperidone or risperidone, or to any of the excipients in the paliperidone extended-release tablet formulation.
Pregnancy (label summary): Pregnancy Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including paliperidone, during pregnancy. Breastfeeding (label summary): 8.3 Females and Males of Reproductive Potential Infertility Females Based on the pharmacologic action of paliperidone (D 2 receptor antagonism), treatment with paliperidone may result in an increase in serum prolactin levels, which may lead to a...
What is Paliperidone used for?
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia Adults: Efficacy was established in three 6-week trials and one maintenance trial. Adolescents (ages 12 to 17): Efficacy was established in one 6-week trial.
How does Paliperidone work?
Paliperidone is the major active metabolite of risperidone. The mechanism of action of paliperidone in schizophrenia is unclear.
What are the side effects of Paliperidone?
The following adverse reactions are discussed in more detail in other sections of the labeling: Increased mortality in elderly patients with dementia-related psychosis Cerebrovascular adverse reactions, including stroke, in elderly patients with dementia-related psychosis Neuroleptic malignant syndrome QT prolongation...
Who should not take Paliperidone?
Paliperidone extended-release tablets are contraindicated in patients with a known hypersensitivity to either paliperidone or risperidone, or to any of the excipients in the paliperidone extended-release tablet formulation.
Does Paliperidone have a boxed warning?
INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Paliperidone extended-release tablets are not approved for the treatment of patients with dementia-related psychosis.
Can I take Paliperidone in pregnancy or while breastfeeding?
Pregnancy (label summary): Pregnancy Exposure Registry There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including paliperidone, during pregnancy.
What is the dose of Paliperidone?
Not provided here. Ask a doctor or pharmacist.
Paliperidone क्या है?
Paliperidone is used for: Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia Adults: Efficacy was established in three 6-week trials and one maintenance trial. It belongs to the class: Atypical Antipsychotic. Common side effects include: The following a…
स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference
US FDA DailyMed; NLM RxNorm